Document is current
Any future updates will be listed below
-
Authors
Fuster-RuizdeApodaca, M. J.
Pérez-Garín, D.
Baceiredo, V.
Laguía, A.
Carrillo, J. García
García, R.
García, D.
-
Funding
Funding for this research was provided by:
ViiV Healthcare
- License Information
-
More Information
Article History
Received: 10 January 2023
Accepted: 29 August 2023
First Online: 13 September 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The Ethics Committee of Ethics Committees of the university hospitals Virgen Macarena and Virgen del Rocío granted approval.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: This work was supported by a Positive Action Europe grant awarded by ViiV Healthcare. Maria J. Fuster-RuizdeApodaca has received consultancy fees from Gilead, Janssen, MSD, ViiV, GSK, and Theratechnologies, and has received payments for lectures or educational presentations from Gilead, Janssen, MSD, and ViiV. D. Pérez-Garín and A. Laguía declare they have no competing interest. Adhara/Sevilla Checkpoint association receives non-conditioned funds for consulting and research from Gilead, Janssen, MSD, ViiV, and Theratechnologies.
